Biogen’s continued focus on developing an effective alzhiemers drug reflects progress and uncertainty in the global fight against the disease
India is positioning medical research as a central pillar in its long-term strategy to achieve developed nation status by 2047
Emcure has tightened its grip on Gennova with a Rs 231.8 crore acquisition. The deal will make Gennova a wholly owned subsidiary of the company.
Artificial intelligence (AI) is transforming every stage of the pharmaceutical value chain, from identifying disease targets to optimizing clinical trials and commercializing innovative therapies
Differentiated products in India are gaining strong momentum as pharmaceutical companies are increasingly focusing on innovation-led drug development to meet medical needs
India's NHM Webinar Series could become a key platform for improving public health across the country.
India’s pharmaceutical sector witnessed a dynamic week marked by drug innovation, regulatory tightening, global collaborations, and infrastructure investments
India has marked a significant milestone in global eye care as the WHO redesignates the L V Prasad Eye Institute as the Centre for Prevention of Blindness until 2030
India’s healthcare ecosystem is witnessing a steady transformation, driven by rising research and development (R&D) initiatives and increased investments in scientific infrastructure
Godavari Biorefineries has achieved a milestone in the global battle against cancer with the Japanese patenting of its anti-cancer molecule
, CDSCO.jpg)